Filing Flows › Tango Therapeutics (TNGX) › How it makes money
How Tango Therapeutics (TNGX) makes money
Tango Therapeutics (TNGX) made $53.8M of revenue in the third quarter 2025 (Q3 2025), +364% from a year earlier. Of every dollar of revenue, 26¢ was left as operating profit, 30¢ was left as net earnings.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q3 2025 | % of revenue |
|---|---|---|
| Revenue | $53.8M | 100.0% |
| Operating profit | $14.1M | 26.2% |
| Net earnings | $15.9M | 29.5% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2025 | $53.8M | +364% |
| Q2 2025 | $3.2M | -84% |
| Q1 2025 | $5.4M | -17% |
| Q4 2024 | $4.1M | -24% |
From Tango Therapeutics' 10-Q filed Nov 4, 2025 (on EDGAR).
Questions
How does Tango Therapeutics make money?
Tango Therapeutics (TNGX) made $53.8M of revenue in the third quarter 2025 (Q3 2025), +364% from a year earlier. Of every dollar of revenue, 26¢ was left as operating profit, 30¢ was left as net earnings.
What is Tango Therapeutics' profit margin?
Net earnings were $15.9M, 29.5% of revenue, in the third quarter 2025; the operating margin was 26.2%.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.